Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation

Background: Previous reports have shown that vaccination rates of adult at-risk populations are low in Turkey. There are differing reports with regards to the effectiveness of the influenza and the pneumococcal polysaccharide vaccine (PPSV23) on the clinical outcomes of community acquired pneumonia...

Full description

Bibliographic Details
Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Ezgi Demirdogen Cetinoglu, Esra Uzaslan, Abdullah Sayıner, Aykut Cilli, Oguz Kılınc, Aysın Sakar Coskun, Armağan Hazar, Nurdan Kokturk, Ayten Filiz, Mehmet Polatli, on behalf of TURCAP Study Group
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-09-01
Subjects:	adults community-aquired pneumonia influenza vaccination pneumococcal polysaccharide vaccination vaccination status
Online Access:	http://dx.doi.org/10.1080/21645515.2017.1339851

Similar Items

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Vaccination against pneumococcal infections in adults
by: Kozlov R.S., et al.
Published: (2018-02-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
by: Salil Bendre, et al.
Published: (2024-02-01)

Vaccination in Adults with 23 valent Pneumococcal Polysaccharide Vaccine –ABC: Awareness, Benefits and Clinical Aspects
by: Salil Bendre, et al.
Published: (2024-02-01)

The New Era of Pneumococcal Vaccination in Adults: What Is Next?
by: Lale Ozisik
Published: (2025-05-01)

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024
by: King-Pui Florence Chan, et al.
Published: (2025-05-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
by: Deborah Lehmann, et al.
Published: (2017-12-01)

A brief history of and future prospects for pneumococcal vaccination in Malaysia
by: Alex J. J. Lister, et al.
Published: (2023-08-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
by: Angel Vila-Córcoles, et al.
Published: (2023-04-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study
by: Jiachen Wang, et al.
Published: (2023-12-01)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialResearch in context
by: Heidi Smith-Vaughan, et al.
Published: (2023-03-01)

Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
by: Germaine Hanquet, et al.
Published: (2022-01-01)

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01)

Effectiveness of vaccine dosing schedules for pneumococcal invasive disease in children: A systematic review and meta-analysis
by: Chia-Yuan Chang, et al.
Published: (2025-12-01)

Pneumococcal Vaccination Coverage Among Adults at Risk in the Russian Federation
by: V. A. Korshunov, et al.
Published: (2025-01-01)

Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom
by: Michele Wilson, et al.
Published: (2023-06-01)

Invasive pneumococcal disease in the post vaccine era: Case report
by: Edwin Albino H. Miranda Choque, et al.
Published: (2016-01-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
by: Jennifer L. Farrar, et al.
Published: (2023-05-01)

Pneumococcal Vaccine for Infants and Toddlers
by: T. Mitchell
Published: (2006-08-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
by: Earnshaw Stephanie R, et al.
Published: (2012-04-01)

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma
by: Tatiana A. Kaliuzhnaia, et al.
Published: (2020-11-01)

A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
by: James Campling, et al.
Published: (2023-12-01)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01)

Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia
by: Vesa Lindström, et al.
Published: (2019-12-01)

Pneumococcal vaccination coverage in individuals (16–59 years) with a newly diagnosed risk condition in Germany
by: Arijita Deb, et al.
Published: (2022-09-01)

The Influence of Introducing Free Vaccination against <i>Streptococcus pneumoniae</i> on the Uptake of Recommended Vaccination in Poland
by: Wojciech Malchrzak, et al.
Published: (2023-12-01)

Pneumococcal vaccination in older adults: A useful, but underused weapon
by: Filipić Brankica
Published: (2025-01-01)

What do Patients Know About Pneumococcal Vaccine?
by: Fatma Çiftci, et al.
Published: (2017-08-01)

Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?
by: Alice Laurence, et al.
Published: (2016-06-01)

Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain
by: I. Rivero-Calle, et al.
Published: (2020-06-01)

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
by: Jeffrey Vietri, et al.
Published: (2020-01-01)

Pneumococcal whole-cell and protein-based vaccines: changing the paradigm
by: Michael E. Pichichero
Published: (2017-12-01)

Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi
by: Daphne Gadama, et al.
Published: (2021-02-01)

Pneumococcal vaccine uptake among high-risk adults and children in Italy: results from the OBVIOUS project survey
by: Zeno Di Valerio, et al.
Published: (2024-03-01)